The mineralocorticoid receptor: A journey exploring its diversity and specificity of action

Molecular Endocrinology

Volumn 19, Issue 9, 2005, Pages 2211-2221

  Tallec, Laurent Pascual Le ^a   Lombès, Marc ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; STEROID RECEPTOR;

ACETYLATION; AMINO ACID SEQUENCE; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECEPTOR SENSITIVITY; SEQUENCE HOMOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; HUMANS; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER;

EID: 24344433108     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0089     Document Type: Short Survey

References (106)

1. Pearce D, Bhargava A, Cole TJ 2003 Aldosterone: its receptor, target genes, and actions. Vitam Horm 66:29-76
2. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
3. Stockand JD 2002 New ideas about aldosterone signaling in epithelia. Am J Physiol Renal Physiol 282:F559-F576
4. Zennaro MC, Lombès M 2004 Mineralocorticoid resistance. Trends Endocrinol Metab 15:264-270
5. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M 1998 Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301
6. Lifton RP, Gharavi AG, Geller DS 2001 Molecular mechanisms of human hypertension. Cell 104:545-556
7. Pitt B 2004 Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 217:53-58
8. Berger S, Bleich M, Schmid W, Cole TJ, Peters J, Watanabe H, Kriz W, Warth R, Greger R, Schutz G 1998 Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc Natl Acad Sci USA 95:9424-9429
9. Beggah AT, Escoubet B, Puttini S, Cailmail S, Delage V, Ouvrard-Pascaud A, Bocchi B, Peuchmaur M, Delcayre C, Farman N, Jaisser F 2002 Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes. Proc Natl Acad Sci USA 99:7160-7165
10. Le Menuet D, Isnard R, Bichara M, Viengchareun S, Muffat-Joly M, Walker F, Zennaro MC, Lombès M 2001 Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor. J Biol Chem 276:38911-38920
11. Yudt MR, Cidlowski JA 2002 The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Mol Endocrinol 16:1719-1726
12. Morrison N, Harrap SB, Arriza JL, Boyd E, Connor JM 1990 Regional chromosomal assignment of the human mineralocorticoid receptor gene to 4q31.1. Hum Genet 85:130-132
13. Zennaro MC, Keightley MC, Kotelevtsev Y, Conway GS, Soubrier F, Fuller PJ 1995 Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J Biol Chem 270:21016-21020
14. Patel PD, Sherman TG, Goldman DJ, Watson SJ 1989 Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus. Mol Endocrinol 3:1877-1885
15. Kwak SP, Patel PD, Thompson RC, Akil H, Watson SJ 1993 5′-Heterogeneity of the mineralocorticoid receptor messenger ribonucleic acid: differential expression and regulation of splice variants within the rat hippocampus. Endocrinology 133:2344-2350
16. Zennaro MC, Farman N, Bonvalet JP, Lombès M 1997 Tissue-specific expression of α and β messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states. J Clin Endocrinol Metab 82:1345-1352
17. Bloem LJ, Guo C, Pratt JH 1995 Identification of a splice variant of the rat and human mineralocorticoid receptor genes. J Steroid Biochem Mol Biol 55:159-162
18. Bahr V, Bumke-Vogt C, Gotze J, Pfeiffer AF, Diederich S 2004 Function of human mineralocorticoid receptor splice variant. Eur J Endocrinol 151:295
19. Wickert L, Selbig J, Watzka M, Stoffel-Wagner B, Schramm J, Bidlingmaier F, Ludwig M 2000 Differential mRNA expression of the two mineralocorticoid receptor splice variants within the human brain: structure analysis of their different DNA binding domains. J Neuroendocrinol 12:867-873
20. Zhou MY, Gomez-Sanchez CE, Gomez-Sanchez EP 2000 An alternatively spliced rat mineralocorticoid receptor mRNA causing truncation of the steroid binding domain. Mol Cell Endocrinol 159:125-131
21. Zennaro MC, Souque A, Viengchareun S, Poisson E, Lombès M 2001 A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol Endocrinol 15:1586-1598
22. Zennaro MC, Le Menuet D, Lombès M 1996 Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms. Mol Endocrinol 10:1549-1560
23. Le Menuet D, Viengchareun S, Penfornis P, Walker F, Zennaro MC, Lombès M 2000 Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice. J Biol Chem 275:7878-7886
24. Sturm A, Bury N, Dengreville L, Fagart J, Flouriot G, Rafestin-Oblin ME, Prunet P 2005 11-deoxycorticosterone is a potent agonist of the rainbow trout (Oncorhynchus mykiss) mineralocorticoid receptor. Endocrinology 146:47-55
25. Fagart J, Wurtz JM, Souque A, Hellal-Levy C, Moras D, Rafestin-Oblin ME 1998 Antagonism in the human mineralocorticoid receptor. EMBO J 17:3317-3325
26. Rogerson FM, Brennan FE, Fuller PJ 2004 Mineralocorticoid receptor binding, structure and function. Mol Cell Endocrinol 217:203-212
27. Binart N, Lombès M, Rafestin-Oblin ME, Baulieu EE 1991 Characterization of human mineralocorticosteroid receptor expressed in the baculovirus system. Proc Natl Acad Sci USA 88:10681-10685
28. Pratt WB, Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360
29. Lombès M, Binart N, Delahaye F, Baulieu EE, Rafestin-Oblin ME 1994 Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists. Biochem J 302:191-197
30. Nishi M, Ogawa H, Ito T, Matsuda KI, Kawata M 2001 Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants. Mol Endocrinol 15:1077-1092
31. Savory JG, Prefontaine GG, Lamprecht C, Liao M, Walther RF, Lefebvre YA, Hache RJ 2001 Glucocorticoid receptor homodimers and glucocorticoid- mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol Cell Biol 21:781-793
32. Hollenberg SM, Evans RM 1988 Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899-906
33. Hellal-Levy C, Fagart J, Souque A, Wurtz JM, Moras D, Rafestin-Oblin ME 2000 Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor. Mol Endocrinol 14:1210-1221
34. Farman N, Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280:F181-F192
35. Heery DM, Kalkhoven E, Hoare S, Parker MG 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736
36. Tajima T, Kitagawa H, Yokoya S, Tachibana K, Adachi M, Nakae J, Suwa S, Katoh S, Fujieda K 2000 A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. J Clin Endocrinol Metab 85:4690-4694
37. Sartorato P, Cluzeaud F, Fagart J, Viengchareun S, Lombès M, Zennaro MC 2004 New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding. Mol Endocrinol 18:2151-2165
38. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
39. Liu W, Wang J, Sauter NK, Pearce D 1995 Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci USA 92:12480-12484
40. Black BE, Holaska JM, Rastinejad F, Paschal BM 2001 DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr Biol 11:1749-1758
41. Govindan MV, Warriar N 1998 Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. J Biol Chem 273:24439-24447
42. Fuse H, Kitagawa H, Kato S 2000 Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol Endocrinol 14:889-899
43. Pascual-Le Tallec L, Kirsh O, Lecomte MC, Viengchareun S, Zennaro MC, Dejean A, Lombès M 2003 Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. Mol Endocrinol 17:2529-2542
44. Jenster G, van der Korput HA, Trapman J, Brinkmann AO 1995 Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 270:7341-7346
45. Hovland AR, Powell RL, Takimoto GS, Tung L, Horwitz KB 1998 An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem 273:5455-5460
46. Pascual-Le Tallec L, Simone F, Viengchareun S, Meduri G, Thirman M, Lombès M 2005 The elongation factor ELL is a selective coregulator for steroid receptor functions. Mol Endocrinol 19:1158-1169
47. Yudt MR, Cidlowski JA 2001 Molecular identification and characterization of a and b forms of the glucocorticoid receptor. Mol Endocrinol 15:1093-1103
48. Pascual-Le Tallec L, Demange C, Lombès M 2004 Human mineralocorticoid receptor A and B protein forms produced by alternative translation sites display different transcriptional activities. Eur J Endocrinol 150:585-590
49. Alnemri ES, Maksymowych AB, Robertson NM, Litwack G 1991 Overexpression and characterization of the human mineralocorticoid receptor. J Biol Chem 266:18072-18081
50. Marissal-Arvy N, Lombès M, Petterson J, Moisan MP, Mormede P 2004 Gain of function mutation in the mineralocorticoid receptor of the Brown Norway rat. J Biol Chem 279:39232-39239
51. Marissal-Arvy N, Mormede P 2004 Excretion of electrolytes in Brown Norway and Fischer 344 rats: effects of adrenalectomy and of mineralocorticoid and glucocorticoid receptor ligands. Exp Physiol 89:753-765
52. Le Moellic C, Ouvrard-Pascaud A, Capurro C, Cluzeaud F, Fay M, Jaisser F, Farman N, Blot-Chabaud M 2004 Early nongenomic events in aldosterone action in renal collecting duct cells: PKCα activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response. J Am Soc Nephrol 15:1145-1160
53. Massaad C, Houard N, Lombès M, Barouki R 1999 Modulation of human mineralocorticoid receptor function by protein kinase A. Mol Endocrinol 13:57-65
54. Ismaili N, Garabedian MJ 2004 Modulation of glucocorticoid receptor function via phosphorylation. Ann NY Acad Sci 1024:86-101
55. Wallace AD, Cidlowski JA 2001 Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276:42714-42721
56. Deroo BJ, Rentsch C, Sampath S, Young J, DeFranco DB, Archer TK 2002 Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol Cell Biol 22:4113-4123
57. Seeler JS, Dejean A 2003 Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 4:690-699
58. Poukka H, Karvonen U, Janne OA, Palvimo JJ 2000 Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 97:14145-14150
59. Iniguez-Lluhi JA, Pearce D 2000 A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol Cell Biol 20:6040-6050
60. Kotaja N, Karvonen U, Janne OA, Palvimo JJ 2002 PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol 22:5222-5234
61. Abdel-Hafiz H, Takimoto GS, Tung L, Horwitz KB 2002 The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J Biol Chem 277:33950-33956
62. Chauchereau A, Amazit L, Quesne M, Guiochon-Mantel A, Milgrom E 2003 Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J Biol Chem 278:12335-12343
63. Nishida T, Yasuda H 2002 PIAS1 and PIASxα function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J Biol Chem 277:41311-41317
64. Fan M, Long X, Bailey JA, Reed CA, Osborne E, Gize EA, Kirk EA, Bigsby RM, Nephew KP 2002 The activating enzyme of NEDD8 inhibits steroid receptor function. Mol Endocrinol 16:315-330
65. Fu M, Wang C, Zhang X, Pestell RG 2004 Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 68:1199-1208
66. Margueron R, Duong V, Castet A, Cavailles V 2004 Histone deacetylase inhibition and estrogen signalling in human breast cancer cells. Biochem Pharmacol 68:1239-1246
67. Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, Hache RJ, Lefebvre YA 1999 Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 19:1025-1037
68. Thomas M, Dadgar N, Aphale A, Harrell JM, Kunkel R, Pratt WB, Lieberman AP 2004 Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts. J Biol Chem 279:8389-8395
69. Freiman RN, Tjian R 2003 Regulating the regulators: lysine modifications make their mark. Cell 112:11-17
70. Desterro JM, Rodriguez MS, Hay RT 1998 SUMO-1 modification of IκBα inhibits NF-κB activation. Mol Cell 2:233-239
71. White PC, Mune T, Agarwal AK 1997 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18:135-156
72. Lombès M, Kenouch S, Souque A, Farman N, Rafestin-Oblin ME 1994 The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 135:834-840
73. Hellal-Levy C, Fagart J, Souque A, Rafestin-Oblin ME 2000 Mechanistic aspects of mineralocorticoid receptor activation. Kidney Int 57:1250-1255
74. Rogerson FM, Dimopoulos N, Sluka P, Chu S, Curtis AJ, Fuller PJ 1999 Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. J Biol Chem 274:36305-36311
75. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP 2000 Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289:119-123
76. Rafestin-Oblin ME, Souque A, Bocchi B, Pinon G, Fagart J, Vandewalle A 2003 The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related. Endocrinology 144:528-533
77. Rogerson FM, Fuller PJ 2003 Interdomain interactions in the mineralocorticoid receptor. Mol Cell Endocrinol 200:45-55
78. Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T, Kato S 2002 Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Mol Cell Biol 22:3698-3706
79. Pearce D, Yamamoto KR 1993 Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259:1161-1165
80. Rupprecht R, Arriza JL, Spengler D, Reul JM, Evans RM, Holsboer F, Damm K 1993 Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol Endocrinol 7:597-603
81. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
82. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F 2003 Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763
83. Auzou G, Fagart J, Souque A, Hellal-Levy C, Wurtz JM, Moras D, Rafestin-Oblin ME 2000 A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11β-substituted spirolactones. Mol Pharmacol 58:684-691
84. Meijer OC, Kalkhoven E, van der Laan S, Steenbergen PJ, Houtman SH, Dijkmans TF, Pearce D, de Kloet ER 2005 Steroid receptor coactivator-1 splice variants differentially afffect corticosteroid receptor signaling. Endocrinology 146:1438-1448
85. Kressler D, Schreiber SN, Knutti D, Kralli A 2002 The PGC-1-related protein PERC is a selective coactivator of estrogen receptor α. J Biol Chem 277:13918-13925
86. Zennaro MC, Le Menuet D, Viengchareun S, Walker F, Ricquier D, Lombès M 1998 Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J Clin Invest 101:1254-1260
87. Hittelman AB, Burakov D, Iniguez-Lluhi JA, Freedman LP, Garabedian MJ 1999 Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J 18:5380-5388
88. Zhou K, Choe KT, Zaidi Z, Wang Q, Mathews MB, Lee CG 2003 RNA helicase A interacts with dsDNA and topoisomerase IIα. Nucleic Acids Res 31:2253-2260
89. Obradovic D, Tirard M, Nemethy Z, Hirsch O, Gronemeyer H, Almeida OF 2004 DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells - toward a basis for the opposite actions elicited by two nuclear receptors? Mol Pharmacol 65:761-769
90. Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW 1996 An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271:1873-1876
91. Sims 3rd RJ, Belotserkovskaya R, Reinberg D 2004 Elongation by RNA polymerase II: the short and long of it. Genes Dev 18:2437-2468
92. Shilatifard A, Haque D, Conaway RC, Conaway JW 1997 Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex. J Biol Chem 272:22355-22363
93. Auboeuf D, Honig A, Berget SM, O'Malley BW 2002 Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298:416-419
94. Planey SL, Litwack G 2000 Glucocorticoid-induced apoptosis in lymphocytes. Biochem Biophys Res Commun 279:307-312
95. Planey SL, Derfoul A, Steplewski A, Robertson NM, Litwack G 2002 Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain. J Biol Chem 277:42188-42196
96. Hu X, Lazar MA 1999 The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402:93-96
97. Privalsky ML 2004 The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315-360
98. Schulz M, Eggert M, Baniahmad A, Dostert A, Heinzel T, Renkawitz R 2002 RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J Biol Chem 277:26238-26243
99. Wang Q, Anzick S, Richter WF, Meltzer P, Simons Jr SS 2004 Modulation of transcriptional sensitivity of mineralocorticoid and estrogen receptors. J Steroid Biochem Mol Biol 91:197-210
100. Lin DY, Fang HI, Ma AH, Huang YS, Pu YS, Jenster G, Kung HJ, Shih HM 2004 Negative modulation of androgen receptor transcriptional activity by Daxx. Mol Cell Biol 24:10529-10541
101. Moilanen AM, Karvonen U, Poukka H, Yan W, Toppari J, Janne OA, Palvimo JJ 1999 A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J Biol Chem 274:3700-3704
102. Tan J, Hall SH, Hamil KG, Grossman G, Petrusz P, Liao J, Shuai K, French FS 2000 Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Mol Endocrinol 14:14-26
103. Kotaja N, Aittomaki S, Silvennoinen O, Palvimo JJ, Janne OA 2000 ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol Endocrinol 14:1986-2000
104. Jimenez-Lara AM, Heine MJ, Gronemeyer H 2002 PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2. FEBS Lett 526:142-146
105. Gross M, Yang R, Top I, Gasper C, Shuai K 2004 PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene 23:3059-3066
106. Tirard M, Jasbinsek J, Almeida OF, Michaelidis TM 2004 The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells. J Mol Endocrinol 32:825-841